// App-Quantinova.ai

3531 : Safety and Immunogenicity of High Dose Trivalent Inactivated Influenza Vaccine in Pediatric Patients with Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Haydar Frangoul

Principal Investigators

  • Jonathan McCullers

  • Wenli Wang

  • Steve Ampath

  • Alice -Shea

  • Natasha Halasa

Medical Centers

  • St. Jude Children's Research Hospital, Memphis, TN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Influenza

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 19

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Immunoglobulin G

Drug/Treatment

  • High dose trivalent inactivated influenza vaccine

  • Trivalent influenza vaccine

Outcome

  • N/A

Study Design

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved